IL109187A0 - Biologically active polypeptide fusion dimers - Google Patents

Biologically active polypeptide fusion dimers

Info

Publication number
IL109187A0
IL109187A0 IL10918794A IL10918794A IL109187A0 IL 109187 A0 IL109187 A0 IL 109187A0 IL 10918794 A IL10918794 A IL 10918794A IL 10918794 A IL10918794 A IL 10918794A IL 109187 A0 IL109187 A0 IL 109187A0
Authority
IL
Israel
Prior art keywords
biologically active
active polypeptide
polypeptide fusion
dimers
fusion dimers
Prior art date
Application number
IL10918794A
Other languages
English (en)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of IL109187A0 publication Critical patent/IL109187A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/49Platelet-derived growth factor [PDGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL10918794A 1993-04-01 1994-03-31 Biologically active polypeptide fusion dimers IL109187A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4163593A 1993-04-01 1993-04-01

Publications (1)

Publication Number Publication Date
IL109187A0 true IL109187A0 (en) 1994-06-24

Family

ID=21917547

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10918794A IL109187A0 (en) 1993-04-01 1994-03-31 Biologically active polypeptide fusion dimers

Country Status (10)

Country Link
US (1) US5705484A (fi)
EP (2) EP0618227A1 (fi)
JP (1) JPH08503858A (fi)
AU (1) AU6497294A (fi)
CA (1) CA2159499A1 (fi)
FI (1) FI954657A (fi)
IL (1) IL109187A0 (fi)
NO (1) NO953882L (fi)
WO (1) WO1994022916A1 (fi)
ZA (1) ZA942206B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238890B1 (en) * 1994-02-18 2001-05-29 Washington University Single chain forms of the glycoprotein hormone quartet
MX9601320A (es) * 1994-08-12 1997-05-31 Univ Washington Formas de cadena unica de cuarteto de hormona de glicoproteina.
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
US5994104A (en) * 1996-11-08 1999-11-30 Royal Free Hospital School Of Medicine Interleukin-12 fusion protein
US6165476A (en) * 1997-07-10 2000-12-26 Beth Israel Deaconess Medical Center Fusion proteins with an immunoglobulin hinge region linker
US6187564B1 (en) 1997-07-10 2001-02-13 Beth Israel Deaconess Medical Center DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
US6242570B1 (en) 1997-07-10 2001-06-05 Beth Israel Deaconess Medical Center Production and use of recombinant protein multimers with increased biological activity
US6635256B1 (en) * 1998-10-19 2003-10-21 Washington University Glycoprotein hormone compositions comprising two β subunits and methods of use thereof
US6103501A (en) * 1997-11-17 2000-08-15 Washington University Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof
US20060263382A1 (en) * 1998-06-20 2006-11-23 Richard Hotchkiss Membrane-permeant peptide complexes for treatment of sepsis
US8038984B2 (en) 1998-06-20 2011-10-18 Washington University Membrane-permeant peptide complexes for treatment of sepsis
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
JP2002529081A (ja) * 1998-11-06 2002-09-10 プレジデント アンド フェローズ オブ ハーバード カレッジ 生物学的事象のfk506に基づく調節
US7109317B1 (en) 1998-11-06 2006-09-19 President And Fellows Of Harvard College FK506-based regulation of biological events
AU7546600A (en) * 1999-10-08 2001-04-23 Biofocus Discovery Limited Methods and compositions for targeting a cell
WO2003068802A2 (en) * 2002-02-11 2003-08-21 Zymogenetics, Inc. Materials and methods for preparing dimeric growth factors
CN103717614A (zh) 2011-08-09 2014-04-09 普罗法尔马封闭式股份公司 重组蛋白质的衍生物、粒细胞集落刺激因子的同多聚体及其制备方法
EP2854834A4 (en) 2012-05-30 2016-05-18 Biostrategies LC PLANT LECTINES AS AN EXCIPIENT OF RELATED MEDICINAL SUBSTANCES IN ANIMAL AND HUMAN CELLS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766073A (en) * 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
EP0259632B1 (en) * 1986-08-13 1995-12-13 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0325224B1 (en) * 1988-01-22 1996-07-31 ZymoGenetics, Inc. Methods of producing secreted receptor analogs

Also Published As

Publication number Publication date
EP0691989A1 (en) 1996-01-17
NO953882L (no) 1995-11-28
ZA942206B (en) 1994-10-31
WO1994022916A1 (en) 1994-10-13
US5705484A (en) 1998-01-06
CA2159499A1 (en) 1994-10-13
FI954657A (fi) 1995-10-23
JPH08503858A (ja) 1996-04-30
EP0618227A1 (en) 1994-10-05
NO953882D0 (no) 1995-09-29
AU6497294A (en) 1994-10-24
FI954657A0 (fi) 1995-09-29

Similar Documents

Publication Publication Date Title
AU4382193A (en) BPI-immunoglobulin fusion proteins
ZA942206B (en) Biologically active polypeptide fusion dimers
GB9112553D0 (en) Fusion proteins
GB8907148D0 (en) Biologically active proteins
EP0644769A4 (en) BIOLOGICALLY ACTIVE PEPTIDES WITH N-TERMINAL SUBSTITUTIONS.
GB9315303D0 (en) Polypeptide
GB9314802D0 (en) Modified proteins
GB9203803D0 (en) A recombinant polypeptide
GB9318901D0 (en) Multiple branch peptide construction
PL299367A1 (en) Linear peptides
GB9321469D0 (en) Insecticidal proteins
AU6582694A (en) Biologically active peptides
IL101747A0 (en) C-terminal modified osteogenic growth polypeptides
ZA934094B (en) BPI-immunoglobulin fusion proteins
EP0873349A4 (en) TYPE III POLYPEPTIDE ACTIVATOR OF MONOCYTES AND ENDOTHELIAL CELLS
GB9304311D0 (en) Anti-viral fusion peptides
GB9215829D0 (en) Anti-viral fusion peptides
GB9205276D0 (en) Anti-viral fusion peptides
GB9313961D0 (en) Chimaeric proteins
GB9311328D0 (en) Protein engineering
AU8219991A (en) Recombinant secretable fusion proteins
GB9324818D0 (en) Peptide
ZA949266B (en) Proteins
GB9321468D0 (en) Insecticidal protein
ZA94383B (en) Optically active beta-aminoalkoxyborane complex